THYSSENKRUPP NUCERA O.N./ DE000NCA0001 /
| 2024-08-30 7:32:30 PM | Chg. +0.150 | Volume | Bid7:42:06 PM | Ask7:42:06 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 9.235EUR | +1.65% | 50 Turnover: 462.250 |
-Bid Size: - | -Ask Size: - | 940.5 mill.EUR | - | 156.75 |
Business description
Thyssenkrupp nucera AG & Co. KGaA operates as a green hydrogen electrolysis technology company. The Company specializes in engineering, procurement, and construction of electrochemical plants and providing green hydrogen, chlor-alkali, and hydrochloric acid solutions. thyssenkrupp nucera serves clients worldwide.
Management board & Supervisory board
| CEO |
|---|
| Dr. Werner Ponikwar |
| Management board |
| Dr. Arno Pfannschmidt, Fulvio Federico |
| Supervisory board |
| Dr. Volkmar Dinstuhl, Paolo Dellachà, Jennifer Cooper, Markus Fuhrmann, Michael Höllermann, Dr. Arnd Köfler, Dr. Sebastian Lochen, Miguel Ángel López Borrego, Prof. Dr. Franca Ruhwedel, Dr. Robert Scannell |
Company data
| Name: | THYSSENKRUPP NUCERA O.N. |
| Address: | Vosskuhle 38, Harpen-Haus,44141 Dortmund |
| Phone: | - |
| Fax: | - |
| E-mail: | dortmund@thyssenkrup...era.com dortmund@thyssenkrupp-nucera.com |
| Internet: | https://thyssenkrupp-nucera.com/ |
| Industry: | Biotechnology |
| Sector: | Biotechnology |
| Sub sector: | Biotechnology |
| End of financial year: | 09-30 |
| Free Float: | 17.96% |
| IPO date: | 2023-07-07 |
Investor relations
| Name: | Dr. Hendrik Finger |
| IR phone: | +49 231 229 724 347 |
| IR Fax: | - |
| IR e-mail: | ir@thyssenkrupp-nucera.com |
Company calendar
| CW 51 | 2024-12-17 Annual Report |
Main Shareholders
| thyssenkrupp AG | 50.19% | |
| De Nora S.p.A. | 25.85% | |
| Free Float | 17.96% | |
| Energy Solutions Company | 6.00% |
